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Abstrak 
 
Objektif 
Untuk mengenal pasti faktor-faktor risiko yang menyebabkan pembedahan laparoskopik diubah 
kepada pembedahan cholesistektomi terbuka. 
Metodologi 
Kajian berbentuk retrospektif dari rekod pesakit-pesakit yang telah menjalani pembedahan 
‘laparoscopic cholecystectomy’ dari Januari 2008 hingga Disember 2009 di HRPZ II. Semua 
faktor risiko pesakit di rekodkan dan di analisis.  
Keputusan 
Daripada 82 rekod yang di semak, sebanyak 11 pesakit (13.4%) memerlukan penukaran 
prosedur. Berdasarkan analisis, didapati faktor-faktor risiko seperti umur, jantina, penyakit ‘co-
morbid’, sejarah pembedahan di abdomen adalah tiada kaitan ketara secara statistik. Demam, 
radang kelenjar pancreas, dan juga keputusan ultrasound yang menunjukkan terdapat penebalan 
dinding pundi hempedu atau ‘pericholecystic fluid’ juga tidak mempunyai kaitan yang ketara 
dari segi statistik. Didapati, faktor risiko seperti cholesistitis akut ((p-value=0.06, adjusted 
OR=13.365) dan  batu di dalam salur hempedu (CBD)( p-value=0.07, adjusted OR=9.278) 
adalah mempunyai kaitan yang ketara yang menyebabkan kepada penukaran kepada 
pembedahan cholesistektomi terbuka.      
Kesimpulan 
Cholesistitis akut dan batu di dalam salur hempedu mempunyai kaitan yang ketara dari segi 
statistik terhadap penukaran pembedahan ‘open cholecystectomy’ daripada ‘laparoscopic 
cholecystectomy.’  
xvi 
 
Abstract  
 
Objective: 
To identify risk factor/s for conversion to open cholecystectomy. 
Methodology 
A retrospective records review was carried out. Records of all patients who underwent 
laparoscopic cholecystectomy from January 2008 till December 2009 in Hospital Raja 
Perempuan Zainab II (HRPZ II), Kota Bharu, Kelantan were reviewed and all risk factors were 
documented. Risks factors for conversion were analysed. 
Results  
Of 82 records reviewed, 11 (13.4%) require conversion to open cholecystectomy.  Age, gender, 
co-morbidity and history of prior abdominal surgery were not statistically significant to the 
conversion rate.  Fever, pancreatitis and ultrasound findings of thickened gallbladder wall or 
pericholecystic fluid collection were not associated with significant risk of conversion.   
There were significant associations between acute cholecystitis (p-value=0.06, adjusted 
OR=13.365) and stone in the common bile duct (p-value=0.07, adjusted OR=9.278) with 
conversion to open cholecystectomy.  
Conclusion 
Acute cholecystitis and presence of stone in the common bile duct were associated with higher 
incidence of conversion to open cholecystectomy. 
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INTRODUCTION 
 
Gall stones have been found in the gallbladders of Egyptian mummies dating back to 
1000 b.c. The incidence of gall stones varies throughout the world as a result of ethnic, dietary 
and poorly understood demographic factors. In USA, autopsy studies performed suggest that gall 
stones are present in at least 20% of women and 8% of men over 40 years of age. In Europe, 
rates of cholelithiasis range from 8 to 34 % in women and 5 to 13 % in men.  
Gallstones are seldom found in children less than 10 years. The prevalence of gallstones 
increases with age, highest at 50 to 60 years in both men and women and the male to female ratio 
is 1.7 to 4:1 (Jazrawi, 2002). 
Since the introduction of laparoscopic cholecystectomy in late 1980’s, it rapidly and 
almost completely replaced the open method. Advantages of laparoscopic cholecystectomy over 
traditional open cholecystectomy include reduced postoperative recovery time, shorter 
hospitalization, reduced pain, improved cosmesis, and rapid return to normal activities. However, 
not all cases can be completed laparoscopically and conversion to open cholecystectomy is then 
required. Conversion rates for both acute and chronic cholecystitis have been reported in many 
series and range from 2 to 20% with an average of 5%. The most common reasons of conversion 
are inability to delineate the anatomy secondary to adhesions or inflammation, unexpected 
operative findings, and iatrogenic injuries.  
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1. LITERATURE REVIEW 
1.1 Anatomy  
The gallbladder is a muscular membranous sac that stores and concentrates bile (Rogers, 
2010b). It is a pear shaped reservoir in a fossa on the inferior surface of the right lobe (Chaurasia, 
1995). It is about 7–10 cm long with an average capacity of 30–50 mL. When obstructed, the 
gallbladder can distend markedly and contain up to 300 mL (Oddsdottir and Hunter, 2006).  
   The fossa of the gallbladder extends from the right end of the porta hepatis to the 
inferior border of the liver. It is divided into fundus, body and neck (Chaurasia, 1995).  
The fundus projects beyond the inferior border of the liver, in the angle between the 
lateral border of the right rectus abdominis and the ninth costal cartilage. It is entirely surrounded 
by peritoneum and is related anteriorly to the anterior abdominal wall, and posteriorly to the 
beginning of the transverse colon (Chaurasia, 1995).  
The body lies in the fossa for the gallbladder on the liver. The upper narrow end of the 
body is continuous with the neck at the right end of the porta hepatis. The superior surface of the 
body is devoid of peritoneum, and is adherent to the liver. The inferior surface is covered with 
the peritoneum (Chaurasia, 1995).  
The neck is the narrow upper end of the gall bladder. It is situated near the right end of 
the porta hepatis. It first curves anterosuperiorly and then posteroinferiorly to become continuous 
with the cystic duct. Its junction with the cystic duct is marked by a constriction. Superiorly, the 
neck is attached to the liver by areolar tissue in which the cystic vessels are embedded. 
Inferiorly, it is related to the first part of the duodenum. The mucous membrane of the neck is 
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folded spirally to prevent any obstruction to the inflow or outflow of bile. The posteromedial 
wall or the neck is dilated outward to form a pouch known as Hartmann’s pouch which is 
directed downward and backward. Gallstone may lodge in this pouch (Chaurasia, 1995).  
   
Figure 1  : Anatomy of the gallbladder 
(Netter, 2006) 
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The cystic duct is about 3-4 cm long. It begin at the neck of the gall bladder, runs 
downward, backward and to the left and ends by joining the common hepatic duct at an acute 
angle to form the common bile duct (Chaurasia, 1995). Bile in the hepatic duct of the liver flows 
through the cystic duct into the gallbladder (Scanlon and Sanders, 2006).  
 The same peritoneal lining that covers the liver covers the fundus and the inferior surface 
of the gallbladder (Oddsdottir and Hunter, 2006).  
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1.2 Histology  
The gallbladder is lined by a single, highly folded, tall columnar epithelium that contains 
cholesterol and fat globules. The epithelial lining of the gallbladder is supported by a lamina 
propria (Oddsdottir and Hunter, 2006).  
The muscle layer has circular longitudinal and oblique fibers, but without well-developed 
layers. The perimuscular subserosa contains connective tissue, nerves, vessels, lymphatics, and 
adipocytes (Oddsdottir and Hunter, 2006).  
It is covered by the serosa except where the gallbladder is embedded in the liver. The 
gallbladder differs histologically from the rest of the gastrointestinal tract in that it lacks a 
muscularis mucosa and submucosa (Oddsdottir and Hunter, 2006). 
 
Figure 2  : Histology of gall bladder  
(PennState, 2008) 
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1.3 Physiology 
 
 
1.3.1 Gall bladder function 
 
The main functions of the gallbladder are (Oddsdottir and Hunter, 2006): 
• to concentrate bile 
• to store hepatic bile  
• regulate the flow and deliver bile into the duodenum in response to a meal. 
 
 
1.3.2 Bile  
 
Bile, also known as gall is a greenish yellow secretion that is produced in the liver and 
passed to the gallbladder for concentration, storage, or transport into the first part of the small 
intestine, the duodenum (Rogers, 2010a). 
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1.3.2.1 Function of bile 
 
 
Bile serves two important functions 
• Role in fat digestion and absorption 
• Bile acids in the bile help to emulsify the large fat particles of the food into many 
minute particles, the surface of which can then be attacked by lipase enzymes secreted 
in pancreatic juice (Guyton and Hall, 2006) 
• Aid in absorption of the digested fat end products through the intestinal mucosal 
membrane (Guyton and Hall, 2006) 
 
• Bile serves as a mean for excretion of several important waste products from the blood.  
• These include especially bilirubin, an end product of hemoglobin destruction, and 
excesses of cholesterol (Guyton and Hall, 2006).  
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1.3.2.2 Bile formation 
 
Bile is secreted in two stages by the liver. The initial portion is secreted by the principal 
functional cells of the liver, the hepatocytes.  The bile then flows in the canaliculi toward 
gallbladder (Guyton and Hall, 2006).  
This initial secretion contains large amount of bile acids, cholesterol, and other organic 
constituents. It is secreted into minute bile canaliculi that originate between the hepatic cells 
(Guyton and Hall, 2006). 
Next, the bile flows in the canaliculi towards the interlobular septa, where the canaliculi 
empty into terminal bile ducts and then into progressively larger ducts, finally reaching the 
hepatic duct and common bile duct. From these the bile either empties directly into the 
duodenum or is stored and concentrated in the gallbladder, shown in Figure 3 (Guyton and Hall, 
2006). 
In its course through the bile ducts, a second component of liver secretion is added to the 
initial bile. This additional secretion is a watery solution of sodium and bicarbonate ions secreted 
by secretory epithelial cells that line the ductules and ducts. This second type of secretion 
sometimes increases the total quantity of bile by as much as an additional 100 per cent. The 
second secretion is stimulated especially by secretin, which causes release of additional 
quantities of bicarbonate ions to supplement the bicarbonate ions in pancreatic secretion (to 
neutralize acid that empties into the duodenum from the stomach) (Guyton and Hall, 2006).  
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Figure 3  : Liver secretion and gallbladder emptying 
(Guyton and Hall, 2006) 
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1.3.2.3 Storing and Concentrating of Bile in the Gallbladder.  
 
 
Bile is secreted continually by the liver cells, but most of it is normally stored in the 
gallbladder until needed in the duodenum. As much as 12 hours of bile secretion (usually about 
450 mls) can be stored in the gallbladder because water, sodium, chloride, and most other small 
electrolytes are continually absorbed through the gallbladder mucosa, concentrating the 
remaining bile constituents that contain the bile salts, cholesterol, lecithin, and bilirubin (Guyton 
and Hall, 2006). 
Most of this gallbladder absorption is caused by active transport of sodium through the 
gallbladder epithelium, and this is followed by secondary absorption of chloride ions, water, and 
most other diffusible constituents. Bile is normally concentrated in this way about 5-fold, but it 
can be concentrated up to a maximum of 20-fold (Guyton and Hall, 2006).  
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1.3.2.4 Composition of bile 
 
 Bile is made up of the bile salts, bile pigments, and other substances dissolved in an 
alkaline electrolyte solution that resembles pancreatic juice (Table 1). About 500 mL is secreted 
per day (Ganong, 2001).  
Table 1 shows that by far the most abundant substances secreted in the bile are bile salts, 
which account for about one half of the total solutes also in the bile. Also secreted or excreted in 
large concentrations are bilirubin, cholesterol, lecithin, and the usual electrolytes of plasma 
(Guyton and Hall, 2006). 
In the concentrating process in the gallbladder, water and large portions of the 
electrolytes (except calcium ions) are reabsorbed by the gallbladder mucosa; essentially all other 
constituents, especially the bile salts and the lipid substances cholesterol and lecithin, are not 
reabsorbed and, therefore, become highly concentrated in the gallbladder bile (Guyton and Hall, 
2006). 
Some of the components of the bile are reabsorbed in the intestine and then excreted 
again by the liver (enterohepatic circulation) (Ganong, 2001).  
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Composition     Liver bile Gall bladder bile 
Water (g/dL) 97.5 92 
Bile salts (g/dL) 1.1 6 
Bilirubin (g/dL) 0.04 0.3 
Cholesterol (g/dL) 0.1 0.3-0.9 
Fatty acids (g/dL)  0.12 0.3-1.2 
Lecithin (g/dL) 0.04 0.3 
Na+ 145.04  (mmol/L) 130 
K+ 5  (mmol/L) 12 
Ca2+ 5  (mmol/L) 23 
Cl- 100  (mmol/L) 25 
HCO3- 28  (mmol/L) 10 
 
Table 1  : Composition of bile 
 (Guyton and Hall, 2006) 
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1.3.2.5 Emptying of the Gallbladder 
 
When food begins to be digested in the upper gastrointestinal tract, the gallbladder begins 
to empty, especially when fatty foods reach the duodenum about 30 minutes after a meal. The 
mechanism of gallbladder emptying is rhythmical contractions of the wall of the gallbladder, but 
effective emptying also requires simultaneous relaxation of the sphincter of Oddi, which guards 
the exit of the common bile duct into the duodenum (Guyton and Hall, 2006).  
Contraction of the muscle wall in the gallbladder is stimulated by the vagus nerve of the 
parasympathetic system and by cholecystokinin hormone , which is produced in the upper 
portion of the intestine (Rogers, 2010a). Substances that cause contraction of the gallbladder are 
called cholagogues (Ganong, 2001). The stimulus for cholecystokinin entry into the blood from 
the duodenal mucosa is mainly by the presence of fatty foods in the duodenum (Guyton and Hall, 
2006). 
In addition to cholecystokinin, the gallbladder is stimulated less strongly by 
acetylcholine-secreting nerve fibers from both the vagi and the intestinal enteric nervous system. 
They are the same nerves that promote motility and secretion in other parts of the upper 
gastrointestinal tract. In summary, the gallbladder empties its store of concentrated bile into the 
duodenum mainly in response to the cholecystokinin stimulus that itself is initiated mainly by 
fatty foods. When fat is not in the food, the gallbladder empties poorly, but when significant 
quantities of fat are present, the gallbladder normally empties completely in about 1 hour. Figure 
4 summarizes the secretion of bile, its storage in the gallbladder, and its ultimate release from the 
bladder to the duodenum (Guyton and Hall, 2006).  
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1.3.3 Gall stone 
 
1.3.3.1 Pathophysiology 
 
Changes in bile acid metabolism and gallbladder function are critical factors in the 
pathogenesis of gallstones (Smelt, 2010). The combination of a diet high in saturated fats and a 
sedentary lifestyle in a population that is generally overweight creates an environment prone to 
gallstone formation (Rakel, 2007). 
There are two main types of stones, cholesterol stones (80%) and pigment or calcium 
stones (20%) (Rakel, 2007). The estimated prevalence of gallstone disease are 10–20% in the 
adult population, affecting more often women than men (Smelt, 2010). 
The pathogenesis of gallstones is multifactorial, based on a complex interaction of 
environmental and genetic factors (Marschall et al., 2010). 
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Figure 4  : Formation of gall stone 
 (Guyton and Hall, 2006)  
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1.3.3.2 Hepatic hypersecretion and bile supersaturation with cholesterol  
In patients with gallstones (particularly obese patients), the liver secretes high levels of 
cholesterol, probably because of increased cholesterol synthesis. This can lead to cholesterol 
supersaturation as the result of an increased cholesterol: bile acid ratio in the bile (Jazrawi, 
2002).  
Cholesterol is very insoluble in bile, and it is maintained in solution in micelles only at 
certain concentrations of bile salts and lecithin (Figure 5). At concentrations above line ABC in 
Figure 5, the bile is supersaturated and contains small crystals of cholesterol in addition to 
micelles (Ganong, 2001). 
In bile that has a composition described by any point below line ABC (eg, point P), 
cholesterol is solely in micellar solution; points above line ABC describe bile in which there are 
cholesterol crystals as well (Small, 1968). 
 
Figure 5  : Cholesterol solubility in bile as a function of the proportions of lecithin, bile 
salts, and cholesterol. 
(Small, 1968) 
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1.3.3.3 Enhanced cholesterol crystal nucleation  
 
Cholesterol crystals nucleate out of solution faster in bile from those with gallstones than 
in that from healthy individuals. This probably results from the overall hydrophilic/hydrophobic 
balance of all proteins in bile (Jazrawi, 2002).  
Bile secreted by individuals with gallstones contains a higher percentage of arachidonic 
acid–rich phospholipids and a secondary bile acid, deoxycholic acid (DCA), both of which have 
an inflammatory and irritating effect on the gallbladder epithelium. This results in more mucus 
production, which can worsen gallbladder symptoms and stone formation (Rakel, 2007).  
 
1.3.3.4 Gallbladder motility defects  
Gallbladder motility defects have been described in several situations, including 
pregnancy, diabetes, patients taking female sex hormones, following parenteral nutrition, 
acromegalic patients taking octreotide (a synthetic somatostatin analogue) and patients 
undergoing rapid weight loss. In all these situations, there is an increased risk of gallstone 
formation (Jazrawi, 2002).  
Delayed emptying prolongs the residence time of cholesterol in the gallbladder resulting 
in more nucleation and crystallization (Smelt, 2010). Stasis in the gallbladder leads to cholesterol 
precipitation and gallstone growth. Other motility defects include reduced postprandial 
gallbladder refilling and turnover of bile, resulting in stasis of gallbladder contents. These 
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motility defects have also been found in patients in whom gallstones recur following non-
surgical therapy (Jazrawi, 2002). 
 
1.3.3.5 Intestinal motility defects  
Prolonged intestinal transit, longer migrating cycles and disrupted motilin release have 
been reported in patients with gallstones. Prolonged intestinal transit has been reported in 
acromegalic patients following octreotide therapy, with an increased risk of gallstone formation 
(Jazrawi, 2002). 
 
Figure 6  : Pathophysiology of gallstone formation 
(Rakel, 2007) 
 
Figure 7  : Pathogenesis of gallstone formation. 
 (Dayan et al., 2004) 
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Cholesterol stones (Walton and Lobo, 2008, Jazrawi, 2002)  
• Greater age 
• Female gender 
• Family history and genetic factors (increased risk in first-degree relatives) 
• Obesity, weight reduction 
• Residence in a developed country (incidence also high in North American 
Indians) 
• Clofibrate (increases cholesterol secretion by the liver) 
• Ceftriaxone (forms complexes with calcium in gallbladder bile that precipitate 
out of solution) 
• Octreotide (a somatostatin analogue used in acromegaly and 
gastroenteropancreatic neuroendocrine tumours) 
• Gastrointestinal motility disorders 
• Parenteral nutrition (reduces gallbladder motility) 
• Pregnancy, oral contraceptives and hormone replacement therapy 
• Diabetes mellitus, cystic fibrosis, ileal disease and loss 
• Surgery (e.g. vagotomy, biliopancreatic bypass) 
 
Pigment stones (Jazrawi, 2002) 
• Chronic haemolysis (haemoglobinopathies) 
• Biliary infection, inflammation and infestation 
• Cirrhosis 
• Residence in the Far East (cirrhosis caused by viral hepatitis is common, and 
bile duct infestation by the liver fluke Clonorchis sinensis causes stones that 
may contain dead parasites) 
• Total parenteral nutrition 
 
Table 2  : Risk factors for gallstone formation 
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1.3.3.6 Sign and symptoms 
 Gallstone disease is one of the most common diseases involving the hepatobiliary 
systems. It carries a substantial burden to health care system. The incidence of gallstone is 
increasing due to the increase number of aging population (Marschall et al., 2010). Gallstones 
may be symptomatic or found incidentally. Symptoms arise due to stones in the gallbladder, in 
the bile duct, or both (Walton and Lobo, 2008).  
Most patients with gallstones (up to 70%) are asymptomatic or have nonspecific 
dyspeptic symptoms (Jazrawi, 2002). Gallstones are often found incidentally in patients 
undergoing investigation for other reasons (Walton and Lobo, 2008). 
The asymptomatic gallstone carries low risk of developing complications. Recent studies 
indicate that the yearly incidence of  complications is 0.3%, while the risk of gallbladder cancer 
is as low as 0.02% (Portincasa et al., 2006). For these reasons, silent stone are usually managed 
conservatively with no medical or surgical intervention (Howard and Fromm, 1999). 
For unknown reasons some patients progress to a symptomatic stage. Most symptoms 
and signs are caused by complications of gallstone disease (Table 2) (Jazrawi, 2002).  
Symptoms attributable to gallbladder stones manifest in a number of ways. In 
uncomplicated cases, the main sign is tenderness in the right upper quadrant during episodes of 
biliary colic (Jazrawi, 2002). Approximately 3 percent of asymptomatic individuals develop 
biliary colic each year (Oddsdottir and Hunter, 2006). Once symptomatic, patients tend to have 
recurring bouts of biliary colic. The probability of recurrence of symptom after 1 year is about 
50% and as high as 70% after 2 years (Howard and Fromm, 1999). 
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Biliary colic is the only specific symptom of uncomplicated gallstone disease. It occurs in 
less than 10% of individuals with gallstones. It comprises sudden-onset, severe epigastric or right 
upper abdominal pain that lasts for several hours, usually radiates to the back and is sometimes 
accompanied by nausea and vomiting. The intensity rises to a crescendo; however, patients often 
believe it to be constant, and thus fluctuations may not be apparent (Jazrawi, 2002). This biliary 
pain produce when gallstone block or obstruct the cystic or common bile duct (Howard and 
Fromm, 1999).  
  Symptomatic gallstone disease may progress to complications related to the gallstones. 
In this symptomatic gallstone, they have spectrum of presentation from acute or chronic 
cholecystitis, biliary colic, pancreatitis or obstructive jaundice. In severe form of acute 
cholecystitis, 10% - 30% of patient will develop life threatening complication such as empyema, 
gangrene or perforation of gallbladder (Hadad et al., 2007b). Rarely, complication of gallstones 
is the presenting picture (Oddsdottir and Hunter, 2006).  
 
Figure 8  : Pain typically experienced during an attack of biliary colic 
 (Moser and Roslyn, 2001). 
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Size of the gallstone is also very important which has been shown to influence the type of 
complication. There is four fold greater risk of developing acute pancreatitis with gallstone 
smaller than 5 mm diameter (Howard and Fromm, 1999).  
On the other hand, the prolonged presence of gallbladder stone of more than 3 cm may be 
a risk in the development of gallbladder carcinoma. The calcification (porcelain) gallbladder is 
also a risk factor for gallbladder cancer (Howard and Fromm, 1999).    
 
1.3.3.7 Complication 
Complication Symptoms Signs 
Stone impaction in  
common bile duct 
Biliary colic Jaundice 
Acute cholecystitis Fever, abdominal pain, 
nausea, vomiting 
Murphy’s sign  (localized 
tenderness over gallbladder) 
Chronic cholecystitis Nonspecific  
 
Nonspecific  
abdominal pain 
Acute pancreatitis Abdominal and  back pain, 
vomiting, collapse  
Hypotension, tenderness 
with rebound 
Acute cholangitis Pain, fever, rigors Jaundice 
 
Table 3  : Common complications of gallstone disease 
(Jazrawi, 2002) 
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1.3.3.8 Investigations  
 
1.3.3.8.1 Blood Tests 
 
 
• Full blood count  
• An elevated white blood cell (WBC) count may indicate or raise suspicion of 
cholecystitis (Oddsdottir and Hunter, 2006).  
 
• Liver function test  
• If associated with an elevation of conjugated bilirubin, alkaline phosphatase, and 
aminotransferase, cholangitis should be suspected.  
• Cholestasis, an obstruction to bile flow, is characterized by an elevation of bilirubin and 
a rise in alkaline phosphatase. Serum aminotransferases may be normal or mildly 
elevated (Oddsdottir and Hunter, 2006). 
• In patients with biliary colic, blood tests typically will be normal. 
 
1.3.3.8.2 Ultrasonography 
• An ultrasound will show stones in the gallbladder with sensitivity and specificity of 
over 90 percent (Oddsdottir and Hunter, 2006).  
• Abdominal ultrasonography is more sensitive than plain x-ray in detecting small 
stones and biliary sludge, and patients are not exposed to radiation. Plain abdominal 
radiography detects only about 20% of stones (those that are calcified)  (Jazrawi, 
2002). 
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• In acute cholecystitis, a layer of edema is seen within the wall of the gallbladder or 
between the gallbladder and the liver.  
• A contracted, thick-walled gallbladder indicates chronic cholecystitis. 
 
1.3.3.8.3 Oral Cholecystography 
 
• Oral Cholecystography involves oral administration of a radiopaque compound that is 
absorbed, excreted by the liver, and passed into the gallbladder (Oddsdottir and 
Hunter, 2006). It is insensitive in detecting small stones (Jazrawi, 2002). 
• Oral cholecystography is of no value in patients with intestinal malabsorption, 
vomiting, obstructive jaundice, and hepatic failure (Oddsdottir and Hunter, 2006). 
 
1.3.3.8.4 Biliary Radionuclide Scanning (HIDA Scan) 
 
• Biliary scintigraphy provides a noninvasive evaluation of the liver, gallbladder, bile 
ducts, and duodenum with both anatomic and functional information (Oddsdottir and 
Hunter, 2006).  
• The primary use of biliary scintigraphy is in the diagnosis of acute cholecystitis, which 
appears as a nonvisualized gallbladder, with prompt filling of the common bile duct 
and duodenum (Oddsdottir and Hunter, 2006). 
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1.3.3.8.5 Computed Tomography 
• Abdominal computed tomography (CT) scans are inferior to ultrasonography in 
diagnosing gallstones (Oddsdottir and Hunter, 2006).  
• CT scan is the test of choice in evaluating the patient with suspected malignancy of the 
gallbladder, the extrahepatic biliary system, or nearby organs, in particular the head of 
the pancreas (Oddsdottir and Hunter, 2006). 
 
 
1.3.3.8.6 Percutaneous Transhepatic Cholangiography 
 
• An intrahepatic bile duct is accessed percutaneously with a small needle under 
fluoroscopic guidance (Oddsdottir and Hunter, 2006).  
 
• Percutaneous transhepatic cholangiography is particularly useful in patients with bile 
duct strictures and tumors, as it defines the anatomy of the biliary tree proximal to the 
affected segment (Oddsdottir and Hunter, 2006). 
 
 
 
 
 
 
 
